These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2970391)

  • 21. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy.
    Long HJ; Schaid DJ; Schutt AJ; Ingle JN; Loprinzi CL; Edmonson JH
    Am J Clin Oncol; 1988 Oct; 11(5):524-7. PubMed ID: 2972192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
    Egorin MJ; Van Echo DA; Whitacre MY; Forrest A; Sigman LM; Engisch KL; Aisner J
    Cancer Res; 1986 Mar; 46(3):1513-20. PubMed ID: 2935249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD
    Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 25. Menogaril: a new anthracycline agent entering clinical trials.
    McGovren JP; Nelson KG; Lassus M; Cradock JC; Plowman J; Christopher JP
    Invest New Drugs; 1984; 2(4):359-67. PubMed ID: 6239835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.
    Cruz JM; Case LD; Dalton HB; Ramseur WL; Richards F; Jackson DV; Muss HB; Zekan PJ; Brodkin RA; Brown RC
    Invest New Drugs; 1992 Apr; 10(1):35-7. PubMed ID: 1535064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
    Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
    J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
    Eisenhauer EA; Pritchard KI; Perrault DJ; Verma S; Pater JL
    Invest New Drugs; 1990 Aug; 8(3):283-7. PubMed ID: 2148741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.
    Skillings J; Cripps C; Eisenhauer E; Pater J; Verma S; Walde D
    Invest New Drugs; 1991 Feb; 9(1):79-82. PubMed ID: 1827434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of oral idarubicin given with a weekly schedule.
    Dodion P; Finet C; Crespeigne N; Beer M; Nicaise C; Rozencweig M; Kenis Y
    Invest New Drugs; 1986; 4(1):31-8. PubMed ID: 3457779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of menogaril (NSC-269148) in colorectal carcinoma. A Southwest Oncology Group study.
    Whitehead RP; Earhart RH; Fleming T; Goodman P; Macdonald JS; Pollock T; Ungerleider JS
    Invest New Drugs; 1990 Aug; 8(3):295-7. PubMed ID: 2148743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS
    Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433
    [No Abstract]   [Full Text] [Related]  

  • 34. Menogaril in the treatment of malignant mesothelioma: a phase II study.
    Hudis CA; Kelsen DP
    Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Cheng EW; Hollander P
    Am J Clin Oncol; 1988 Apr; 11(2):174-6. PubMed ID: 2965856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 37. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.
    Zanette ML; Tirelli U; Sorio R; Zadro D; Figoli F; Monfardini S; D'Incalci M
    Cancer Chemother Pharmacol; 1987; 20(1):67-70. PubMed ID: 2957106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of menogaril in patients with advanced hypernephroma.
    Long HJ; Hauge MD; Therneau TM; Buckner JC; Frytak S; Hahn RG
    Invest New Drugs; 1991 Aug; 9(3):261-2. PubMed ID: 1838363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and disposition of menogaril (NSC 269148) in the rabbit.
    Dodion P; Egorin MJ; Engisch KL; Bachur NR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5352-7. PubMed ID: 2932217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.